Welcome to LookChem.com Sign In|Join Free
  • or
4-HYDROXYMETHYL-BICYCLO[2.2.2]OCTANE-1-CARBOXYLIC ACID is a unique chemical compound characterized by its bicyclic structure, featuring a hydroxymethyl group and a carboxylic acid functional group. This versatile molecule serves as a crucial building block in the synthesis of a variety of pharmaceuticals and biologically active compounds, making it a valuable asset in the development of new drugs and therapeutic agents.

828-52-4

Post Buying Request

828-52-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

828-52-4 Usage

Uses

Used in Pharmaceutical Industry:
4-HYDROXYMETHYL-BICYCLO[2.2.2]OCTANE-1-CARBOXYLIC ACID is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs and therapeutic agents. Its unique structure allows for the creation of molecules with potential medicinal properties.
Used in Medicinal Chemistry Research and Development:
In the field of medicinal chemistry, 4-HYDROXYMETHYL-BICYCLO[2.2.2]OCTANE-1-CARBOXYLIC ACID is utilized as a research compound to explore its potential in the design and synthesis of novel biologically active molecules, furthering our understanding of its applications in drug discovery.
Used in Agrochemical Industry:
4-HYDROXYMETHYL-BICYCLO[2.2.2]OCTANE-1-CARBOXYLIC ACID may also find applications in the agrochemical sector, where it could be employed in the development of new pesticides, herbicides, or other agrochemical products, leveraging its structural properties to enhance crop protection and yield.
Used in Performance Chemicals Industry:
4-HYDROXYMETHYL-BICYCLO[2.2.2]OCTANE-1-CARBOXYLIC ACID's potential extends to the performance chemicals industry, where it could be used in the creation of high-performance materials, such as specialty polymers or advanced materials for various industrial applications, capitalizing on its unique structural attributes.

Check Digit Verification of cas no

The CAS Registry Mumber 828-52-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 8,2 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 828-52:
(5*8)+(4*2)+(3*8)+(2*5)+(1*2)=84
84 % 10 = 4
So 828-52-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H16O3/c11-7-9-1-4-10(5-2-9,6-3-9)8(12)13/h11H,1-7H2,(H,12,13)

828-52-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(hydroxymethyl)bicyclo[2.2.2]octane-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 1-Hydroxymethyl-bicyclo<2.2.2>octan-4-carbonsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:828-52-4 SDS

828-52-4Relevant academic research and scientific papers

Polycyclic compound as well as pharmaceutical composition and application thereof

-

Paragraph 0377; 0378; 0379; 0380, (2018/03/26)

The invention discloses a polycyclic compound as well as a preparation method, a pharmaceutical composition and application thereof. The polycyclic compound (I), isomers, prodrugs, solvent compounds,hydrates, stable isotope derivatives or pharmaceutically

Adenosine receptor antagonists and methods of making and using the same

-

Page/Page column 58, (2008/06/13)

The invention is based on the discovery that compounds of Formula I are unexpectedly highly potent and selective inhibitors of the adenosine A1receptor. Adenosine A1antagonists can be usefull in the prevention and/or treatment of numerous diseases, including cardiac and circulatory disorders, degenerative disorders of the central nervous system, respiratory disorders, and many diseases for which diuretic treatment is suitable. In one embodiment, the invention features a compound of formula I: wherein: R3is an optionally substituted bicyclic, tricylic, or pentacyclic group selected from: ?and wherein R1, R2, R6, X1, X2, and Z are as described in the specification.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 828-52-4